The discovery that a protein called membralin promotes the survival of motor neurons could potentially lead to novel therapies for severe, early-onset motor neuron disease, according to a recent study by SBP investigators. As reported recently in eLife, the researchers developed a novel mouse model for identifying therapeutic targets for a class of motor neuron disorders called distal hereditary motor neuropathies. Continue reading “Newly identified cause of motor neuron disease paves way for better treatments”
Institute News
Newly identified cause of motor neuron disease paves way for better treatments
